1. Implementation rates of uro-oncology multidisciplinary meeting decisions.
- Author
-
Kinnear, Ned, Smith, Riley, Hennessey, Derek B., Bolton, Damien, and Sengupta, Shomik
- Subjects
- *
TUMOR diagnosis , *TERTIARY care , *HISTOLOGY , *RETROSPECTIVE studies , *COMORBIDITY - Abstract
Objectives To assess implementation rates of the consensus plans made at the uro-oncology multidisciplinary meeting ( MDM) of an Australian tertiary centre, and analyse obstacles to implementation. Methods A retrospective review was performed of all patients discussed at the uro-oncology MDM at our institution between 1 January and 30 June 2015. Rates of referral for MDM discussion after a new histological diagnosis of malignancy, categorised by tumour type, were assessed. Patient records were interrogated to confirm MDM plan implementation, with the outcomes examined being completion of MDM plan within 3 months and factors preventing implementation. Results During the enrolment period, from 291 uro-oncological procedures, 240 yielded malignant histology of which 160 (67%) were discussed at the MDM. Overall, 202 patients, including 32 females, were discussed at the uro-oncology MDM. MDM consensus plans were implemented in 184 (91.1%) patients. Reasons for deviation from the MDM plan included delay in care, patient deterioration or comorbidities, patient preference, consultant decision, loss to follow-up, and change in patient scenario due to additional new information. Conclusion The MDM is increasingly important in the care of uro-oncology patients, with about two-thirds of new diagnoses currently captured. There appear to be few barriers to the implementation of consensus plans, with nearly all patients undergoing the recommended management. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF